Trial Profile
A phase II study of accelerated radiotherapy and Temodar [temozolomide] in adults with newly diagnosed glioblastoma multiforme
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2006
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 20 Jul 2006 New trial record.